SARTORIUS (UNSP.ADS)/1/5 - Asset Resilience Ratio
SARTORIUS (UNSP.ADS)/1/5 (SRT0) has an Asset Resilience Ratio of 0.26% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See SARTORIUS (UNSP.ADS)/1/5 short-term liquidity ratio to evaluate short-term liquidity relative to the company's equity base.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2022–2025)
This chart shows how SARTORIUS (UNSP.ADS)/1/5's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see SARTORIUS (UNSP.ADS)/1/5 assets under control.
Liquid Assets Composition Over Time
This chart breaks down SARTORIUS (UNSP.ADS)/1/5's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Read how much debt does SARTORIUS (UNSP.ADS)/1/5 carry for a breakdown of total debt and financial obligations.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | €0.00 | 0% |
| Short-term Investments | €26.10 Million | 0.26% |
| Total Liquid Assets | €26.10 Million | 0.26% |
Asset Resilience Insights
- Limited Liquidity: SARTORIUS (UNSP.ADS)/1/5 maintains only 0.26% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
SARTORIUS (UNSP.ADS)/1/5 Industry Peers by Asset Resilience Ratio
Compare SARTORIUS (UNSP.ADS)/1/5's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Qingdao NovelBeam Technology Co. Ltd. A
SHG:688677 |
Medical Instruments & Supplies | 2.66% |
|
Autek China Inc
SHE:300595 |
Medical Instruments & Supplies | 21.20% |
|
St.Shine Optical Co Ltd
TWO:1565 |
Medical Instruments & Supplies | 1.28% |
|
Safe Orthopaedics SA
PA:ALSAF |
Medical Instruments & Supplies | 2.20% |
|
Ansell Ltd
AU:ANN |
Medical Instruments & Supplies | 7.53% |
|
Nanosonics Ltd
AU:NAN |
Medical Instruments & Supplies | 46.84% |
|
SDI Ltd
AU:SDI |
Medical Instruments & Supplies | 3.36% |
|
Austco Healthcare Ltd
AU:AHC |
Medical Instruments & Supplies | 15.90% |
Annual Asset Resilience Ratio for SARTORIUS (UNSP.ADS)/1/5 (2022–2025)
The table below shows the annual Asset Resilience Ratio data for SARTORIUS (UNSP.ADS)/1/5.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-12-31 | 0.11% | €10.40 Million ≈ $12.16 Million |
€9.72 Billion ≈ $11.36 Billion |
-0.04pp |
| 2024-12-31 | 0.15% | €15.30 Million ≈ $17.89 Million |
€10.10 Billion ≈ $11.81 Billion |
0.00pp |
| 2023-12-31 | 0.15% | €15.00 Million ≈ $17.54 Million |
€9.75 Billion ≈ $11.39 Billion |
-0.29pp |
| 2022-12-31 | 0.44% | €30.90 Million ≈ $36.13 Million |
€6.98 Billion ≈ $8.16 Billion |
-- |
About SARTORIUS (UNSP.ADS)/1/5
Sartorius Aktiengesellschaft provides bioprocess solutions, and lab products and services worldwide. The company offers analytical solutions, such as biolayer interferometry systems, high-throughput screening by cytometry systems, process analytical technology and data analytics, cell selection and retrieval, live-cell imaging and analysis systems, and surface plasmon resonance systems; cell cult… Read more